BioSpace News Archive

Stress about health care on par with stress related to mass shootings

New data from Juniper Research has shown that the total value of B2B cross-border payments immutably stored on blockchain will exceed $4.4 trillion by 2024; up from $171 billion in 2019.

Net sales amounted to 282.7 MSEK (232.2), which is an increase by 21.7 percent compared to the corresponding quarter last year. At comparable exchange rates and adjusted for acqusitions) sales increased by 8.1 percent.

Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, announced that Matthew Pauls is stepping down as president, chief executive officer and director, effective immediately.

Immunic, Inc. announced management’s participation in the following industry and investor conferences in November

Surgery Partners, Inc., a leading short-stay surgical facility owner and operator, announced results for the third quarter ended September 30, 2019.

Viking Therapeutics, Inc. announced its financial results for the third quarter ended September 30, 2019, and provided an update on its clinical pipeline and other corporate developments.

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported its financial results for the third quarter ended September 30, 2019.

Mylan N.V. announced its financial results for the three and nine months ended September 30, 2019.

MYOS RENS Technology Inc., an advanced nutrition company and the owner of Fortetropin®, the unique proprietary bioactive composition made from fertilized egg yolks clinically proven to help build lean muscle, announced the expansion of its animal health business with the launch of “Veterinarian Strength Myos Canine Muscle Formula®.”